Navigation Links
Insect-inspired super rubber moves toward practical uses in medicine

The remarkable, rubber-like protein that enables dragonflies, grasshoppers and other insects to flap their wings, jump and chirp has major potential uses in medicine, scientists conclude in an article in the journal ACS Macro Letters. It evaluates the latest advances toward using a protein called resilin in nanosprings, biorubbers, biosensors and other applications.

Kristi Kiick and colleagues explain that scientists discovered resilin a half-century ago in the wing hinges of locusts and elastic tendons of dragonflies. The extraordinary natural protein tops the best synthetic rubbers. Resilin can stretch to three times its original length, for instance, and then spring back to its initial shape without losing its elasticity, despite repeated stretching and relaxing cycles. That's a crucial trait for insects that must flap or jump millions of times over their lifetimes. Scientists first synthesized resilin in 2005 and have been striving to harness its properties in medicine.

Kiick's team describes how their own research and experiments by other scientists are making major strides toward practical applications of resilin. Scientists have modified resilin with gold nanoparticles for possible use in diagnostics, engineered mosquito-based resin to act like human cartilage and developed a hybrid material for cardiovascular applications. "This increasing amount of knowledge gained from studies on natural resilin and resilin-like polypeptides continues to inspire new designs and applications of recombinant resilin-based biopolymers in biomedical and biotechnological applications," the scientists state.


Contact: Michael Bernstein
American Chemical Society

Page: 1

Related biology news :

1. New nanoglue is thin and supersticky
2. Supercharged safflower
3. New data suggests HIV superinfection rate comparable to initial HIV infection
4. 3-D motion of cold virus offers hope for improved drugs using Australias fastest supercomputer
5. Glyphosate-resistant superweeds may be less susceptible to diseases
6. Belgian scientists develop way to detect superparasites
7. Superfast evolution in sea stars
8. Superbird stuns researchers
9. Super-strong, high-tech material found to be toxic to aquatic animals
10. Towards computing with water droplets -- superhydrophobic droplet logic
11. Pink Lemonade, Razz, Sweetheart, and Caras Choice: superb blueberries from ARS
Post Your Comments:
(Date:11/18/2015)... New York , November 18, 2015 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2021. According to the ... in 2014 and is anticipated to reach US$29.1 bn ... to 2021. North America ...
(Date:11/17/2015)... LIVERMORE, Calif. , Nov. 17, 2015  Vigilant ... has joined its Board of Directors. ... Vigilant,s Board after recently retiring from the partnership at ... owning 107 companies with over $140 Billion in revenue.  ... performance improvement across all the TPG companies, from 1997 ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... that includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, ... applied spectroscopy, covers a wide range of applications such as, but not limited ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
Breaking Biology Technology: